Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-25-006262
Filing Date
2025-02-13
Accepted
2025-02-13 08:30:24
Documents
59
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 924025
2 ex31-1.htm EX-31.1 18579
3 ex31-2.htm EX-31.2 18497
4 ex32-1.htm EX-32.1 8154
5 ex32-2.htm EX-32.2 8308
  Complete submission text file 0001493152-25-006262.txt   4610263

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE inbs-20241231.xsd EX-101.SCH 29521
7 XBRL CALCULATION FILE inbs-20241231_cal.xml EX-101.CAL 56290
8 XBRL DEFINITION FILE inbs-20241231_def.xml EX-101.DEF 79475
9 XBRL LABEL FILE inbs-20241231_lab.xml EX-101.LAB 293578
10 XBRL PRESENTATION FILE inbs-20241231_pre.xml EX-101.PRE 220364
61 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 712063
Mailing Address 135 W 41ST ST, FLOOR 5 NEW YORK NY 10036
Business Address 135 W 41ST ST, FLOOR 5 NEW YORK NY 10036 646-233-6971
INTELLIGENT BIO SOLUTIONS INC. (Filer) CIK: 0001725430 (see all company filings)

EIN.: 821512711 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39825 | Film No.: 25617347
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)